Novoron Bioscience
Latest round
- Seed
Last raised
- Nov 2021
Total raised
- $3M
Investors
- 2
About Novoron Bioscience
Based in San Diego, CA, Novoron Bioscience Inc.Novoron Bioscience Inc. focuses on developing novel therapies for neurodegenerative conditions. The company was founded by A Bright and Shawn Gahr.Novoron Bioscience specializes in the development of innovative therapies aimed at addressing neurodegenerative diseases and enhancing neurological health. The company's core product offerings include small molecule therapies designed to inhibit the spread of prion-like proteins, which contribute to neurodegeneration and cognitive decline. Additionally, Novoron focuses on enhancing the regenerative capacity of the spinal cord following traumatic injuries, creating solutions that promote recovery and restore functionality. Their research and drug development efforts are directed toward both preclinical and clinical applications, with an emphasis on multi-modality discovery and optimized drug delivery.Novoron Bioscience's revenue structure is primarily based on partnerships and collaborations within the pharmaceutical and healthcare sectors. The company engages with research institutions and healthcare providers for the distribution and application of its therapeutic offerings, leveraging strategic alliances to penetrate the market effectively. Revenue generation is facilitated through licensing agreements, development partnerships, and milestone payments associated with the advancement of their drug candidates through various stages of clinical trials. The specifics of pricing and transaction structures are tailored to the unique characteristics of their therapies and the agreements established with their partners, ensuring alignment with regulatory standards and market needs.In November 2021, Novoron Bioscience Inc. The company plans to explore expansion into additional markets within North America and Europe, enhancing their presence in regions where neurodegenerative diseases are prevalent. As Novoron continues to innovate and advance their drug pipeline, they aim to solidify partnerships and collaborations that further support their growth objectives.
Who invested in Novoron Bioscience
2 investors across 2 rounds
See all investors in Novoron Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novoron Bioscience
Who invested in Novoron Bioscience?
Novoron Bioscience has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novoron Bioscience raised?
Novoron Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Novoron Bioscience last raise money?
Novoron Bioscience's most recent round on record is a Seed, in Nov 2021.
What does Novoron Bioscience do?
Based in San Diego, CA, Novoron Bioscience Inc.
Where is Novoron Bioscience headquartered?
Novoron Bioscience is headquartered in San Diego, US.
Which VCs invest in companies like Novoron Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Novoron Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Novoron Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.